ERM (LRRKtide) Substrate
Product Image
引用資料與參考文獻 (1)

ERM (LRRKtide) Substrate

A peptide substrate based upon ezrin/radixin/moesin (ERM) that is phosphorylated by LRRK2 and LRRK2 mutants. For use with the Adapta™深入閱讀
Have Questions?
產品號碼Quantity
PV50931 mL
產品號碼 PV5093
價格 (TWD)
32,480.00
Online offer
Ends: 31-Mar-2026
46,400.00
您節省 13,920.00 (30%)
Each
新增至購物車
Quantity:
1 mL
價格 (TWD)
32,480.00
Online offer
Ends: 31-Mar-2026
46,400.00
您節省 13,920.00 (30%)
Each
新增至購物車
A peptide substrate based upon ezrin/radixin/moesin (ERM) that is phosphorylated by LRRK2 and LRRK2 mutants. For use with the Adapta™ Universal Kinase Assay (PV5099).
For Research Use Only. Not for use in diagnostic procedures.
規格
Amino Acid SequenceRLGRDKYKTLRQIRQ
Assay EntryBiochemical ADP accumulation
Gene ID (Entrez)120892
Molecular Weight (g/mol)1931.2 Da
Quantity1 mL
Shipping ConditionDry Ice
Substratepeptide based upon ezrin/radixin/moesin (ERM)
Target EntryLRRK2 G2019S, LRRK2
Validated KinasesLRRK2
Detection MethodFluorescence
Substrate PropertiesPeptide-Based Substrate
Substrate TypeKinase Substrate
Target EnzymeSerine/Threonine Kinases
Unit SizeEach
內容物與存放
2 mM ERM (LRRKtide) peptide substrate in 50 mM HEPES (pH 7.5), 0.01% Brij-35, 10 mM MgCl2 and 1 mM EGTA. Store at -20°C.

引用資料與參考文獻 (1)

引用資料與參考文獻
Abstract
Investigation of leucine-rich repeat kinase 2 : enzymological properties and novel assays.
Authors:Anand VS, Reichling LJ, Lipinski K, Stochaj W, Duan W, Kelleher K, Pungaliya P, Brown EL, Reinhart PH, Somberg R, Hirst WD, Riddle SM, Steven P B,
Journal:FEBS J
PubMed ID:19076219
Mutations in leucine-rich repeat kinase 2 (LRRK2) comprise the leading cause of autosomal dominant Parkinson's disease, with age of onset and symptoms identical to those of idiopathic forms of the disorder. Several of these pathogenic mutations are thought to affect its kinase activity, so understanding the roles of LRRK2, and ... More